94-2655. Advisory Committee on Immunization Practices: Meeting

[Federal Register Volume 59, Number 25 (Monday, February 7, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-2655]


[[Page Unknown]]

[Federal Register: February 7, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

 

Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices.
    Times and Dates: 8:30 a.m-5 p.m., February 23, 1994. 8:30 a.m.-
4:45 p.m., February 24, 1994.
    Place: CDC, Auditorium A, Building 2, 1600 Clifton Road NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents.
    Matters to be discussed: The committee will discuss ACIP's rule 
in the ``Vaccines for Children Program''; the ``Vaccines for 
Children Program'' update; responses to the proposed Federal 
Register notice on the vaccine schedule recommended for the 
``Vaccines for Children Program''; the status of the simplification 
of the vaccine schedule; an update on large-linked database studies 
of adverse events; the revision of the varicella statement and the 
status of the application for licensure of the varicella vaccine; 
the inactive poliovirus-oral poliovirus schedule; vaccine-associated 
paralytic poliomyelitis in Romania; the need for an adult booster 
dose of acellular pertussis vaccine; an update on the typhoid 
recommendation; the status of BCG vaccine guidelines; the Institute 
of Medicine report on adverse reactions and contraindications to 
vaccines; adolescent vaccination against hepatitis B; hepatitis A 
vaccine; the Department of Defense hepatitis A vaccine trials; 
hepatitis C virus infection in the occupational setting; influenza 
vaccine recommendation for 1994/1995; antiviral agents; the status 
of the development of new vaccine information statements; an update 
on the National Vaccine Program; and an update on the Injury 
Compensation Program. Other matters of relevance among the 
committee's objectives may be discussed.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: Gloria A. Kovach, Committee 
Management Specialist, CDC (1-B72), 1600 Clifton Road NE, Mailstop A20, 
Atlanta, Georgia 30333, telephone [phone].

    Dated: February 1, 1994.
Elvin Hilyer,
Associate Director for Policy Coordination, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 94-2655 Filed 2-4-94; 8:45 am]
BILLING CODE 4160-18-M